What CHIMERIX INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Meyer Robert J. | Director | Apr 21 | Disposition to Issuer · D | −35,150 | $8.55 | −$301K | 0 |
| Demski Martha J | Director | Apr 21 | Disposition to Issuer · D | −72,055 | $8.55 | −$616K | 0 |
| Middleton Fred A | Director | Apr 21 | Disposition to Issuer · D | −207,523 | $8.55 | −$1.77M | 0 |
| Middleton Fred A | Director | Apr 21 | Disposition to Issuer · D | −531,861 | $8.55 | −$4.55M | 0 |
| Middleton Fred A | Director | Apr 21 | Disposition to Issuer · D | −2,776,093 | $8.55 | −$23.7M | 0 |
| Middleton Fred A | Director | Apr 21 | Disposition to Issuer · D | −60,000 | $8.55 | −$513K | 0 |
| Middleton Fred A | Director | Apr 21 | Disposition to Issuer · D | −40,000 | $8.55 | −$342K | 0 |
| Alrutz Michael A | SVP AND GENERAL COUNSEL | Apr 21 | Disposition to Issuer · D | −216,689 | $8.55 | −$1.85M | 0 |
| Andriole Michael T. | PRESIDENT AND CEO | Apr 21 | Disposition to Issuer · D | −630,828 | $8.55 | −$5.39M | 0 |
| Jakeman David | VP OF FINANCE AND ACCOUNTING | Apr 21 | Disposition to Issuer · D | −156,209 | $8.55 | −$1.34M | 0 |
| LaSpaluto Michelle | CHIEF FINANCIAL OFFICER | Apr 21 | Disposition to Issuer · D | −181,541 | $8.55 | −$1.55M | 0 |
| Melemed Allen S. | CHIEF MEDICAL OFFICER | Apr 21 | Disposition to Issuer · D | −173,852 | $8.55 | −$1.49M | 0 |
| Sherman Michael A. | Chief Executive Officer | Apr 21 | Disposition to Issuer · D | −233,413 | $8.55 | −$2M | 0 |
| Sherman Michael A. | Chief Executive Officer | Apr 21 | Disposition to Issuer · D | −102,995 | $8.55 | −$881K | 0 |
| Sherman Michael A. | Chief Executive Officer | Apr 21 | Disposition to Issuer · D | −87,000 | $8.55 | −$744K | 0 |
| Riga Thomas J | COO and CCO | Apr 21 | Disposition to Issuer · D | −60,828 | $8.55 | −$520K | 0 |
| LaSpaluto Michelle | CHIEF FINANCIAL OFFICER | Feb 13 | Open-market sale · S | −2,260 | $4.51 | −$10.2K | 172,977 |
| Alrutz Michael A | SVP AND GENERAL COUNSEL | Feb 13 | Open-market sale · S | −1,600 | $4.52 | −$7.23K | 213,596 |
| Melemed Allen S. | CHIEF MEDICAL OFFICER | Feb 13 | Open-market sale · S | −3,065 | $4.50 | −$13.8K | 152,875 |
| Andriole Michael T. | PRESIDENT AND CEO | Feb 13 | Open-market sale · S | −7,370 | $4.52 | −$33.3K | 609,603 |
Loading...